What is Mycosis Fungoides

Mycosis Fungoides is a rare type of indolent (slow-growing) non-Hodgkin lymphoma that primarily affects the skin, occurring when T-cells in the immune system become abnormal and migrate to the skin. While it is chronic and often requires long-term management, many people with Mycosis Fungoides maintain a good quality of life through skin-directed and systemic therapies.

What exactly is Mycosis Fungoides?

Mycosis Fungoides is the most common form of cutaneous T-cell lymphoma (CTCL). The condition begins when T-lymphocytes (a type of white blood cell) undergo a malignant transformation and infiltrate the epidermis and dermis. Over time, this can lead to skin patches, plaques, or tumors. Unlike many other cancers, Mycosis Fungoides is characterized by a very slow progression, often remaining localized to the skin for years or even decades before potentially spreading to lymph nodes or internal organs.

Who is typically affected by Mycosis Fungoides?

The prevalence of Mycosis Fungoides is estimated at approximately 1 in 350,000 to 1 in 500,000 people. It is more common in men than in women, with a ratio of roughly 2:1. While it can occur at any age, the median age of diagnosis is typically between 55 and 60 years old. It is rarely seen in children. At DiseaseMaps.org, 71 people with Mycosis Fungoides have already joined our community to share their experiences and support one another.

What are the main clinical stages of the disease?

Physicians classify the progression of Mycosis Fungoides based on the appearance and extent of skin involvement. The clinical stages generally include:

• Patch Stage: Flat, red, scaly areas that often resemble eczema or psoriasis.


• Plaque Stage: Raised, thicker, and more well-defined skin lesions.


• Tumor Stage: Nodular growths that are thicker than plaques and may ulcerate.


• Erythrodermic Stage: A rare, advanced form where redness covers more than 80% of the body surface area.

How does it differ from other skin conditions?

Because early-stage Mycosis Fungoides mimics common inflammatory skin conditions like eczema or dermatitis, it is frequently misdiagnosed. A key differentiator is that Mycosis Fungoides does not respond to standard topical steroids or moisturizers in the way that benign skin conditions do. Diagnosis usually requires multiple skin biopsies to confirm the presence of malignant T-cells.

Next steps

• Consult a board-certified dermatologist or an oncologist specializing in cutaneous lymphoma.


• Request a skin biopsy to confirm the diagnosis if you have persistent, treatment-resistant skin patches.


• Join our community at DiseaseMaps.org to connect with 71 other members who understand the journey of living with this condition.

Medical disclaimer: This information is for educational purposes only and does not replace professional medical advice, diagnosis, or treatment.

References

• NIH Genetic and Rare Diseases Information Center (GARD): Mycosis Fungoides


• Orphanet: Cutaneous T-cell lymphoma, rare disease database


• Cutaneous Lymphoma Foundation: Patient education and support resources


• OMIM (Online Mendelian Inheritance in Man): Entry for Mycosis Fungoides